Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-25

FDA Approved: MERCAPTOPURINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves a supplemental application for mercaptopurine submitted by Hikma Pharmaceuticals USA Inc., indicating changes to the product's labeling or approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mercaptopurine (Mercaptopurine)

Snippet

SUPPL AP for MERCAPTOPURINE (MERCAPTOPURINE)